Debates between Lord Giddens and Lord Prior of Brampton during the 2015-2017 Parliament

Mesothelioma (Amendment) Bill [HL]

Debate between Lord Giddens and Lord Prior of Brampton
Friday 20th November 2015

(9 years ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Prior of Brampton Portrait Lord Prior of Brampton
- Hansard - - - Excerpts

We probably cannot today sort out the figures in the way we would like. It will be very difficult to allocate some of the more generic research expenditure. Let us move on from funding, if we can.

Lord Giddens Portrait Lord Giddens
- Hansard - -

Will the Minister get to work on this and send something back about what the precise figures seem to be in the light of the questions raised? This is a serious issue, so it would be good to get a response from the Government.

--- Later in debate ---
Lord Prior of Brampton Portrait Lord Prior of Brampton
- Hansard - - - Excerpts

I thank the noble Lord for that comment. We in this country are often highly self-critical but actually we have a remarkable record on research. We have three of the top medical academic institutions in the world in this country: Oxford, Cambridge and Imperial. We have UCLH, King’s and Manchester. We have some extraordinary research organisations in this country. There is, I guess, an issue over quality and quality control. There are an awful lot of clinicians who do research that may not be to the—

Lord Giddens Portrait Lord Giddens
- Hansard - -

I am sorry to give the Minister such a torrid time, but I hope he recognises that he should look internationally. There are important models in other countries, such as the Pacific Lung Health Centre, which is integrated with the wider lung foundation and has produced significant research. We should not just think nationally; we should look at other models and see how they could be adopted here to deal with the issues that the noble Lord, Lord Winston, rightly raises. As I tried to stress, mesothelioma shares things in common with other cancers and, now that we have got to a deep enough genetic level to be able to understand why some of these processes happen, I think it would be worth while to get some information on what exists elsewhere to see how far it could be applied here.